Back to Screener

Healthcare

PRF Technologies Ltd.(PRFX)

Live Price

Offline

$1.65

-10.81% today

1Y Change

-77.40%

Window

Jun 23, 2025 โ†’ Jun 18, 2026

Market Cap
โ€”
Revenue Growth
0.0%
EPS Growth
+99.1%
Dividend Yield
0.0%

Coverage: 249 bars ยท Jun 23, 2025 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

PRF Technologies Ltd. (PRFX) is a Healthcare stock with listed on NASDAQ. The stock last traded around $1.65 and down 77.4% across the available one-year price window (Jun 23, 2025 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +99.1%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +99.1%, free cash flow +68.7% with operating margin 0.0% and ROIC -33.9%. Stock Foundry combines PRFX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

PRFX

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

PRFX Max Drawdown

-88.69%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for PRFX and SPY.

Calendar-year return history is still loading or unavailable.

EPS Consensus

-7.68

Range -7.68 โ†’ -7.68

No analyst count

vs prior: +93.8%

Revenue Outlook

$0.0B

Range $0.0B โ†’ $0.0B

No analyst count

Consensus Spread

EPS spread0.0%
Revenue spreadโ€”

Lower spread suggests tighter agreement across covering analysts.

Trend

EPS trend

Consensus average across visible periods

-7.68
Latest visible period
Q1 2028Q2 2029
6 visible pointstrend: +93.8%

Trend

Revenue trend

Average analyst revenue estimate

$0.0B
Latest visible period
Q1 2028Q2 2029
6 visible points

Timeline

Analyst forecast ladder

Sorted by period end date. Includes both cached rows and live fallbacks from FMP.

Q2 2029
Ends Jun 30, 2029
quarter
Revenue
$0.0B
$0.0B to $0.0B
EPS
-7.68
-7.68 to -7.68
No analyst count
EPS: No analyst count
Apr 30, 05:15 AM UTC
stable/analyst-estimates
Q1 2029
Ends Mar 30, 2029
quarter
Revenue
$0.0B
$0.0B to $0.0B
EPS
-124.80
-124.80 to -124.80
No analyst count
EPS: No analyst count
Apr 30, 05:15 AM UTC
stable/analyst-estimates
Q4 2028
Ends Dec 30, 2028
quarter
Revenue
$0.0B
$0.0B to $0.0B
EPS
-288.00
-288.00 to -288.00
No analyst count
EPS: No analyst count
Apr 30, 05:15 AM UTC
stable/analyst-estimates
Q3 2028
Ends Sep 30, 2028
quarter
Revenue
$0.0B
$0.0B to $0.0B
EPS
-154.80
-154.80 to -154.80
No analyst count
EPS: No analyst count
Apr 30, 05:15 AM UTC
stable/analyst-estimates
Q2 2028
Ends Jun 30, 2028
quarter
Revenue
$0.0B
$0.0B to $0.0B
EPS
-168.00
-168.00 to -168.00
No analyst count
EPS: No analyst count
Apr 30, 05:15 AM UTC
stable/analyst-estimates
Q1 2028
Ends Mar 30, 2028
quarter
Revenue
$0.0B
$0.0B to $0.0B
EPS
-300.00
-300.00 to -300.00
No analyst count
EPS: No analyst count
Apr 30, 05:15 AM UTC
stable/analyst-estimates

Next Step

Put consensus data in context

Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.